Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00997659 · ClinicalTrials.gov registry record · NA
Chromium's Effect on Insulin Resistance in Obesity
A NA study, sponsored by Stony Brook University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00997659 is a NA study that has completed, run by Stony Brook University. The registered enrollment target is 40 participants.
The verdict
NCT00997659, a NA study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This research is to investigate the nutritional supplement chromium picolinate. A large number of people use chromium picolinate from health food stores to improve the function of the hormone insulin. The investigators are testing how effective this supplement is and are also monitoring its safety. In patients with diabetes, chromium has been shown to increase sensitivity to the hormone insulin. Since obesity can cause insensitivity or resistance to insulin, the investigators are studying obese individuals with documented insulin resistance. The investigators would like to know if chromium is also effective in treating the insulin resistance associated with obesity.
Interventions
- DIETARY_SUPPLEMENT chromium picolinate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-04 |
| Est. Completion | 2010-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00997659
The ClinicalTrials.gov registry entry for NCT00997659 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which chromium picolinate is the first listed.
NCT00997659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00997659 about?
NCT00997659 is a clinical study titled "Chromium's Effect on Insulin Resistance in Obesity". This research is to investigate the nutritional supplement chromium picolinate. A large number of people use chromium picolinate from health food stores to improve the function of the hormone insulin. The investigators are testing how effective this supplement is and are also monitoring its safety. ...
What is the current status of trial NCT00997659?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2007-04. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00997659?
The interventions under investigation include: chromium picolinate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00997659?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.